Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
scientific article published on 14 February 2015
Author/s
author: Hagop Kantarjian, Jorge Eduardo Cortes, Tapan Kadia, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Guillermo Garcia-Manero, Marina Konopleva, Rebecca S Garris, Naval Daver, Michael E Rytting
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.